John W. Walsh Alpha-1 Home Infusion Act of 2025
See what this could mean for your district
Save your district in Account to view district-specific context for this bill.
Bill details
Bill overview
A neutral overview based on official congressional sources.
Introduced in House
John W. Walsh Alpha-1 Home Infusion Act of 2025 This bill provides for Medicare coverage of treatment for alpha-1 antitrypsin (AAT) deficiency (a protein deficiency that raises the risk of lung and other diseases). Specifically, the bill provides for coverage of at-home augmentation therapy for beneficiaries with emphysema as a result of severe hereditary AAT deficiency. Treatment must be provided through qualified home infusion therapy suppliers; beneficiaries must be under the care of a physician, nurse practitioner, or physician assistant.
Related votes
Roll calls that reference this bill in official data.
Primary sources
Official links to verify details. No interpretation.